Axogen, Inc. (AXGN) Financial Statements
Axogen, Inc. (AXGN) reported trailing twelve-month revenue of $251.2M (up 23.6% year on year) and net income of -$33.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $8.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AXGNAxogen, Inc.Follow AXGN — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.8 | 7.7 | 10.9 | 16.8 | 27.3 | 41.1 | 60.4 | 83.9 | 106.7 | 112.3 | 127.4 | 138.6 | 159.0 | 187.3 | 225.2 | 251.2 | |
| Gross profit | 2.4 | 5.7 | 8.5 | 13.4 | 22.5 | 34.6 | 51.1 | 71.0 | 89.4 | 90.7 | 104.4 | 108.8 | 121.9 | 142.0 | 167.4 | 187.3 | |
| Research & development | 0.7 | 1.4 | 2.1 | 3.0 | 3.2 | 4.2 | 6.7 | 11.8 | 17.5 | 17.8 | 24.2 | 25.6 | 27.3 | 27.8 | 32.9 | 36.0 | |
| Operating income | -7.0 | -7.8 | -9.6 | -9.8 | -9.3 | -8.1 | -8.0 | -20.5 | -31.4 | -23.2 | -25.4 | -29.7 | -21.5 | -3.3 | -7.8 | -12.8 | |
| Pre-tax income | -9.2 | -10.2 | -14.6 | -17.7 | -13.4 | -14.4 | -10.4 | -22.4 | -29.1 | -23.8 | -27.0 | -28.9 | -21.7 | -10.0 | -15.7 | -33.5 | |
| Income tax | — | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net income | -9.2 | -9.4 | -14.6 | -17.7 | -13.4 | -14.4 | -10.4 | -22.4 | -29.1 | -23.8 | -27.0 | -28.9 | -21.7 | -10.0 | -15.7 | -33.5 | |
| Diluted EPS ($) | -2.77 | -0.85 | -1.08 | -0.99 | -0.51 | -0.47 | -0.31 | -0.60 | -0.74 | -0.60 | -0.65 | -0.69 | -0.51 | -0.23 | -0.34 | -0.63 | |
| Diluted shares (mn) | — | — | — | — | — | — | — | — | — | — | 41.2 | 42.1 | 42.9 | 44.3 | 46.1 | — |
USD millions · SEC XBRL
Axogen, Inc. — questions
- What is Axogen, Inc.'s revenue?
- $251.2M over the twelve months to 2026-06-30, up 23.6% year on year, from its 10-Q and 10-K filings.
- What is Axogen, Inc.'s net income?
- -$33.5M over the twelve months to 2026-06-30.
- What is Axogen, Inc.'s free cash flow?
- $8.6M over the twelve months to 2026-06-30.
- What are Axogen, Inc.'s diluted earnings per share?
- $-0.63 over the twelve months to 2026-06-30.
Every figure on this page comes from Axogen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.